Caredx to participate in upcoming investor conferences

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) — the transplant company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers — today announced the company will participate in the following investor conferences. jefferies london healthcare conference 2024 in london, uk. presentation on tuesday, november 19 at 9:00 am gmt/4:00 am est.
CDNA Ratings Summary
CDNA Quant Ranking